Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Sell
42
LUCY Quote, Financials, Valuation and Earnings
Last price:
$1.39
Seasonality move
:
-3.75%
Day range:
$1.37 - $1.46
52-week range:
$0.95 - $6.14
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.89x
P/B ratio:
0.73x
Volume:
185.1K
Avg. volume:
6.5M
1-year change:
-76.6%
Market cap:
$7.4M
Revenue:
$1.6M
EPS (TTM):
-$2.62
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LUCY
Innovative Eyewear, Inc.
|
$1.2M | -$0.43 | 73.74% | -50.4% | $3.00 |
|
CATX
Perspective Therapeutics, Inc.
|
$231.1K | -$0.35 | -57.02% | -40.33% | $12.3077 |
|
COO
The Cooper Cos., Inc.
|
$1.1B | $1.11 | 6.12% | 98.37% | $91.06 |
|
KIDS
OrthoPediatrics Corp.
|
$61.3M | -$0.31 | 12.13% | -15.87% | $24.13 |
|
NXGL
NexGel, Inc.
|
$3.2M | -$0.09 | 6.54% | -22.68% | $6.00 |
|
STAA
STAAR Surgical Co.
|
$75.5M | $0.15 | 69.01% | 39.51% | $24.08 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LUCY
Innovative Eyewear, Inc.
|
$1.39 | $3.00 | $7.4M | -- | $0.00 | 0% | 1.89x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.7100 | $12.3077 | $201.5M | -- | $0.00 | 0% | 183.75x |
|
COO
The Cooper Cos., Inc.
|
$81.29 | $91.06 | $15.9B | 43.38x | $0.01 | 0% | 3.97x |
|
KIDS
OrthoPediatrics Corp.
|
$18.11 | $24.13 | $454.1M | -- | $0.00 | 0% | 1.86x |
|
NXGL
NexGel, Inc.
|
$1.67 | $6.00 | $13.6M | -- | $0.00 | 0% | 1.09x |
|
STAA
STAAR Surgical Co.
|
$19.14 | $24.08 | $944.9M | 49.73x | $0.00 | 0% | 4.12x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LUCY
Innovative Eyewear, Inc.
|
1.01% | 5.916 | 1.04% | 9.17x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.042 | 1.3% | 8.47x |
|
COO
The Cooper Cos., Inc.
|
25.25% | -0.042 | 20.32% | 0.89x |
|
KIDS
OrthoPediatrics Corp.
|
22.39% | -0.306 | 21.68% | 3.39x |
|
NXGL
NexGel, Inc.
|
38.1% | 1.021 | 15.76% | 0.82x |
|
STAA
STAAR Surgical Co.
|
9.96% | 0.664 | 2.95% | 4.10x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LUCY
Innovative Eyewear, Inc.
|
$244.8K | -$1.9M | -79.57% | -80% | -287.5% | -$1.5M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
COO
The Cooper Cos., Inc.
|
$601M | $140.4M | 3.45% | 4.56% | 13.18% | $149.9M |
|
KIDS
OrthoPediatrics Corp.
|
$40M | -$4.9M | -10.3% | -12.83% | -7.95% | -$3.4M |
|
NXGL
NexGel, Inc.
|
$1.2M | -$725K | -33.25% | -51.15% | -24.71% | -$793K |
|
STAA
STAAR Surgical Co.
|
$76.6M | $44.5M | -23.38% | -25.83% | 46.96% | $1.8M |
Innovative Eyewear, Inc. vs. Competitors
-
Which has Higher Returns LUCY or CATX?
Perspective Therapeutics, Inc. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of -12425.36%. Innovative Eyewear, Inc.'s return on equity of -80% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital LUCYInnovative Eyewear, Inc.36.64% -$0.38 $10.4M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About LUCY or CATX?
Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 115.83%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 354.16%. Given that Perspective Therapeutics, Inc. has higher upside potential than Innovative Eyewear, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Innovative Eyewear, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LUCYInnovative Eyewear, Inc.0 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is LUCY or CATX More Risky?
Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.
-
Which is a Better Dividend Stock LUCY or CATX?
Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LUCY or CATX?
Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Innovative Eyewear, Inc.'s net income of -$1.8M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 1.89x versus 183.75x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LUCYInnovative Eyewear, Inc.1.89x -- $668.1K -$1.8M CATXPerspective Therapeutics, Inc.183.75x -- $209K -$26M
-
Which has Higher Returns LUCY or COO?
The Cooper Cos., Inc. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of 7.94%. Innovative Eyewear, Inc.'s return on equity of -80% beat The Cooper Cos., Inc.'s return on equity of 4.56%.
Company Gross Margin Earnings Per Share Invested Capital LUCYInnovative Eyewear, Inc.36.64% -$0.38 $10.4M COOThe Cooper Cos., Inc.56.42% $0.43 $11B -
What do Analysts Say About LUCY or COO?
Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 115.83%. On the other hand The Cooper Cos., Inc. has an analysts' consensus of $91.06 which suggests that it could grow by 11.95%. Given that Innovative Eyewear, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe Innovative Eyewear, Inc. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings LUCYInnovative Eyewear, Inc.0 0 0 COOThe Cooper Cos., Inc.6 7 1 -
Is LUCY or COO More Risky?
Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Cooper Cos., Inc. has a beta of 1.028, suggesting its more volatile than the S&P 500 by 2.836%.
-
Which is a Better Dividend Stock LUCY or COO?
Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cooper Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. The Cooper Cos., Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LUCY or COO?
Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are smaller than The Cooper Cos., Inc. quarterly revenues of $1.1B. Innovative Eyewear, Inc.'s net income of -$1.8M is lower than The Cooper Cos., Inc.'s net income of $84.6M. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while The Cooper Cos., Inc.'s PE ratio is 43.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 1.89x versus 3.97x for The Cooper Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LUCYInnovative Eyewear, Inc.1.89x -- $668.1K -$1.8M COOThe Cooper Cos., Inc.3.97x 43.38x $1.1B $84.6M
-
Which has Higher Returns LUCY or KIDS?
OrthoPediatrics Corp. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of -19.22%. Innovative Eyewear, Inc.'s return on equity of -80% beat OrthoPediatrics Corp.'s return on equity of -12.83%.
Company Gross Margin Earnings Per Share Invested Capital LUCYInnovative Eyewear, Inc.36.64% -$0.38 $10.4M KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M -
What do Analysts Say About LUCY or KIDS?
Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 115.83%. On the other hand OrthoPediatrics Corp. has an analysts' consensus of $24.13 which suggests that it could grow by 33.21%. Given that Innovative Eyewear, Inc. has higher upside potential than OrthoPediatrics Corp., analysts believe Innovative Eyewear, Inc. is more attractive than OrthoPediatrics Corp..
Company Buy Ratings Hold Ratings Sell Ratings LUCYInnovative Eyewear, Inc.0 0 0 KIDSOrthoPediatrics Corp.4 1 0 -
Is LUCY or KIDS More Risky?
Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison OrthoPediatrics Corp. has a beta of 1.091, suggesting its more volatile than the S&P 500 by 9.108%.
-
Which is a Better Dividend Stock LUCY or KIDS?
Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OrthoPediatrics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. OrthoPediatrics Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LUCY or KIDS?
Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are smaller than OrthoPediatrics Corp. quarterly revenues of $61.3M. Innovative Eyewear, Inc.'s net income of -$1.8M is higher than OrthoPediatrics Corp.'s net income of -$11.8M. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while OrthoPediatrics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 1.89x versus 1.86x for OrthoPediatrics Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LUCYInnovative Eyewear, Inc.1.89x -- $668.1K -$1.8M KIDSOrthoPediatrics Corp.1.86x -- $61.3M -$11.8M
-
Which has Higher Returns LUCY or NXGL?
NexGel, Inc. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of -22.05%. Innovative Eyewear, Inc.'s return on equity of -80% beat NexGel, Inc.'s return on equity of -51.15%.
Company Gross Margin Earnings Per Share Invested Capital LUCYInnovative Eyewear, Inc.36.64% -$0.38 $10.4M NXGLNexGel, Inc.40.93% -$0.08 $8.8M -
What do Analysts Say About LUCY or NXGL?
Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 115.83%. On the other hand NexGel, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 259.28%. Given that NexGel, Inc. has higher upside potential than Innovative Eyewear, Inc., analysts believe NexGel, Inc. is more attractive than Innovative Eyewear, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LUCYInnovative Eyewear, Inc.0 0 0 NXGLNexGel, Inc.0 0 0 -
Is LUCY or NXGL More Risky?
Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NexGel, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock LUCY or NXGL?
Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NexGel, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. NexGel, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LUCY or NXGL?
Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are smaller than NexGel, Inc. quarterly revenues of $2.9M. Innovative Eyewear, Inc.'s net income of -$1.8M is lower than NexGel, Inc.'s net income of -$647K. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while NexGel, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 1.89x versus 1.09x for NexGel, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LUCYInnovative Eyewear, Inc.1.89x -- $668.1K -$1.8M NXGLNexGel, Inc.1.09x -- $2.9M -$647K
-
Which has Higher Returns LUCY or STAA?
STAAR Surgical Co. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of 9.38%. Innovative Eyewear, Inc.'s return on equity of -80% beat STAAR Surgical Co.'s return on equity of -25.83%.
Company Gross Margin Earnings Per Share Invested Capital LUCYInnovative Eyewear, Inc.36.64% -$0.38 $10.4M STAASTAAR Surgical Co.80.89% $0.18 $392.9M -
What do Analysts Say About LUCY or STAA?
Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 115.83%. On the other hand STAAR Surgical Co. has an analysts' consensus of $24.08 which suggests that it could grow by 25.83%. Given that Innovative Eyewear, Inc. has higher upside potential than STAAR Surgical Co., analysts believe Innovative Eyewear, Inc. is more attractive than STAAR Surgical Co..
Company Buy Ratings Hold Ratings Sell Ratings LUCYInnovative Eyewear, Inc.0 0 0 STAASTAAR Surgical Co.1 9 1 -
Is LUCY or STAA More Risky?
Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison STAAR Surgical Co. has a beta of 1.000, suggesting its less volatile than the S&P 500 by 0.048000000000004%.
-
Which is a Better Dividend Stock LUCY or STAA?
Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. STAAR Surgical Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. STAAR Surgical Co. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LUCY or STAA?
Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are smaller than STAAR Surgical Co. quarterly revenues of $94.7M. Innovative Eyewear, Inc.'s net income of -$1.8M is lower than STAAR Surgical Co.'s net income of $8.9M. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while STAAR Surgical Co.'s PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 1.89x versus 4.12x for STAAR Surgical Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LUCYInnovative Eyewear, Inc.1.89x -- $668.1K -$1.8M STAASTAAR Surgical Co.4.12x 49.73x $94.7M $8.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did AMD Stock Go Up?
Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…
Will Data Centers Be In Space?
With demand for data centers seemingly growing by the day,…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
47
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
56
INTC alert for Jan 26
Intel Corp. [INTC] is down 2.8% over the past day.
Buy
64
BNR alert for Jan 22
Burning Rock Biotech Ltd. [BNR] is down 0% over the past day.
Sell
19
APGE alert for Jan 22
Apogee Therapeutics, Inc. [APGE] is down 0% over the past day.
